PTGX peer analysis
Protagonist Therapeutics (PTGX) against its competitors: price, today's move, 1-year return and market value side by side.
PTGX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.78 | -4.79% | 51.81% | $615.29M |
| ANAB AnaptysBio | $47.02 | -2.61% | 28.93% | $1.44B |
| IMUX Immunic | $7.51 | -3.66% | -4.23% | $102.47M |
| IMVT Immunovant | $28.45 | -2.47% | 14.63% | $6.03B |
| IRON Disc Medicine | $78.57 | -2.81% | -8.37% | $3.59B |
| ODTX Odyssey Therapeutics | $19.54 | -1.46% | – | – |
| SYRE Spyre Therapeutics | $95.55 | -1.05% | 293.84% | – |
| PTGX Protagonist Therapeutics | $139.61 | -3.62% | 79.33% | $9.37B |
- PTGX's peers: ACRS (Aclaris Therapeutics), ANAB (AnaptysBio), IMUX (Immunic), IMVT (Immunovant), IRON (Disc Medicine), ODTX (Odyssey Therapeutics), SYRE (Spyre Therapeutics).
Updated 2026-11-02 23:13 UTC